Cogent Biosciences Is A Biotechnology Company Based In Cambridgemassachusettsfocused On Developing Precision Therapies For Genetically Driven Diseasesthe Company Aims To Discoverdevelopand Commercialize Therapies That Significantly Impact Patients With Genetically Defined Conditionsby Addressing The Underlying Causes Of Diseasescogent Biosciences Seeks To Restore Health And Improve The Quality Of Life For Patients The Company S Main Product Is Bezuclastiniba Drug Candidate Targeting Specific Mutations In The Kit Receptor Tyrosine Kinaseprimarily Used For Treating Systemic Mastocytosis And Advanced Gastrointestinal Stromal Tumorsgist Cogent Biosciences Also Conducts Clinical Trials For Its Drug Candidates And Participates In Scientific Conferences To Share Its Research And Advancementsreflecting Its Commitment To Innovation In The Biotech Field
